O'Sullivan B - Search Results

1

Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma.

Hui AB, Lin A, Xu W, Waldron L, Perez-Ordonez B, Weinreb I, Shi W, Bruce J, Huang SH, O'Sullivan B, Waldron J, Gullane P, Irish JC, Chan K, Liu FF. Hui AB, et al. Clin Cancer Res. 2013 Apr 15;19(8):2154-62. doi: 10.1158/1078-0432.CCR-12-3572. Epub 2013 Mar 4. Clin Cancer Res. 2013. PMID: 23459718

2

Accuracy of recorded tumor, node, and metastasis stage in a comprehensive cancer center.

Brierley JD, Catton PA, O'Sullivan B, Dancey JE, Dowling AJ, Irish JC, McGowan TS, Sturgeon JF, Swallow CJ, Rodrigues GB, Panzarella T. Brierley JD, et al. J Clin Oncol. 2002 Jan 15;20(2):413-9. doi: 10.1200/JCO.2002.20.2.413. J Clin Oncol. 2002. PMID: 11786568

3

Molecular pathology parameters in human nasopharyngeal carcinoma.

Shi W, Pataki I, MacMillan C, Pintilie M, Payne D, O'Sullivan B, Cummings BJ, Warde P, Liu FF. Shi W, et al. Cancer. 2002 Apr 1;94(7):1997-2006. doi: 10.1002/cncr.0679. Cancer. 2002. PMID: 11932902 Free article.

4

Results of radiotherapy for primary subglottic squamous cell carcinoma.

Paisley S, Warde PR, O'Sullivan B, Waldron J, Gullane PJ, Payne D, Liu FF, Bayley A, Ringash J, Cummings BJ. Paisley S, et al. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1245-50. doi: 10.1016/s0360-3016(01)02759-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955735

5

Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary?

Chow E, Payne D, O'Sullivan B, Pintilie M, Liu FF, Waldron J, Warde P, Cummings B. Chow E, et al. Radiother Oncol. 2002 Jun;63(3):269-74. doi: 10.1016/s0167-8140(02)00132-9. Radiother Oncol. 2002. PMID: 12142090

6

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.

Warde P, O'Sullivan B, Aslanidis J, Kroll B, Lockwood G, Waldron J, Payne D, Bayley A, Ringash J, Kim J, Liu FF, Maxymiw W, Sprague S, Cummings BJ. Warde P, et al. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):9-13. doi: 10.1016/s0360-3016(02)02890-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182969 Clinical Trial.

7

Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States.

Groome PA, O'Sullivan B, Irish JC, Rothwell DM, Schulze K, Warde PR, Schneider KM, Mackenzie RG, Hodson DI, Hammond JA, Gulavita SP, Eapen LJ, Dixon PF, Bissett RJ, Mackillop WJ. Groome PA, et al. J Clin Oncol. 2003 Feb 1;21(3):496-505. doi: 10.1200/JCO.2003.10.106. J Clin Oncol. 2003. PMID: 12560441

8

Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma.

Mäkitie AA, MacMillan C, Ho J, Shi W, Lee A, O'Sullivan B, Payne D, Pintilie M, Cummings B, Waldron J, Warde P, Irish J, Brown D, Gilbert R, Gullane P, Liu FF, Kamel-Reid S. Mäkitie AA, et al. Clin Cancer Res. 2003 Jun;9(6):2177-84. Clin Cancer Res. 2003. PMID: 12796384

9

Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma.

Waldron J, Tin MM, Keller A, Lum C, Japp B, Sellmann S, van Prooijen M, Gitterman L, Blend R, Payne D, Liu FF, Warde P, Cummings B, Pintilie M, O'Sullivan B. Waldron J, et al. Radiother Oncol. 2003 Aug;68(2):153-61. doi: 10.1016/s0167-8140(02)00370-5. Radiother Oncol. 2003. PMID: 12972310

10

Organ preservation and functional rehabilitation in head and neck: introduction.

Gullane PJ, O'Sullivan B. Gullane PJ, et al. World J Surg. 2003 Jul;27(7):804. doi: 10.1007/s00268-003-7095-4. World J Surg. 2003. PMID: 14509510 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

912 results

Search Page

Filters